+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Softgel Capsules Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 182 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5941775
Free Webex Call
10% Free customization

Gelatin-Based/Animal-Based is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Softgel Capsules Market, valued at USD 8.02 Billion in 2024, is projected to experience a CAGR of 7.86% to reach USD 12.63 Billion by 2030. Softgel capsules represent a specialized oral dosage form, comprising a liquid or semi-liquid fill enclosed within a soft, gelatinous shell typically composed of animal gelatin or plant-based polymers. The market's growth is primarily driven by several distinct factors, including the inherent benefits of softgel formulations such as improved bioavailability and ease of swallowing, increased demand for dietary supplements and nutraceuticals, and the rising prevalence of chronic diseases necessitating effective drug delivery. These attributes facilitate enhanced patient compliance and expand application across pharmaceutical, nutraceutical, and cosmetic sectors.

Key Market Drivers

The global softgel capsules market expansion is significantly propelled by the growing demand for dietary supplements and nutraceuticals, alongside rising consumer health awareness and a proactive approach to preventive healthcare. The burgeoning nutraceutical sector, which frequently utilizes softgel formulations for their effective delivery of active ingredients, remains a primary catalyst.

According to the IADSA, at the start of 2023, the worldwide market for supplements was larger than USD 170 billion, underscoring the substantial base driving softgel production in this segment. This robust demand is further amplified by a global shift towards preventative health measures and increased consumer understanding of nutrition's role in well-being. This trend encourages a consistent uptake of supplements, for which softgels offer an appealing and convenient dosage form.

Key Market Challenges

A significant challenge impeding the expansion of the global softgel capsules market is the high production costs associated with specialized encapsulation machinery, stringent manufacturing controls, and the rising prices of raw materials. These economic factors directly influence the operational profitability and growth strategies of manufacturers within the sector. The substantial investment required for advanced encapsulation technologies, alongside the ongoing expenses of maintaining rigorous quality and regulatory compliance, significantly elevates overall manufacturing overheads.

Key Market Trends

The growing consumer preference for vegan and vegetarian products, coupled with increasing health and ethical considerations, is significantly driving the adoption of plant-based encapsulation materials in the softgel capsules market. This trend involves a shift from traditional animal-derived gelatin to alternatives such as pullulan, starch, and hydroxypropyl methylcellulose, which cater to a broader demographic seeking ethical and sustainable options.

The move towards plant-based ingredients is evident in manufacturing capacity, with the Pharmaceutical Research and Manufacturers of America (PhRMA) reporting that Catalent alone accounted for nearly 14% of global plant-based capsule manufacturing capacity in 2023. This expansion underscores the market's response to evolving dietary preferences and clean label demands. In a notable development, IFF introduced new pectin-based technology in April 2023 to expand its vegan softgel offerings, reflecting industry innovation in sustainable solutions.

Key Market Players Profiled:

  • Fuji Capsule Co Ltd
  • Sirio Pharma Co Ltd
  • Captek Softgel International Inc
  • Thermo Fisher Scientific Inc
  • EyePoint Pharmaceuticals Inc
  • Catalent Inc
  • EuroCaps Ltd
  • Aenova Group GmbH
  • Lonza Group AG
  • Soft Gel Technologies Inc.

Report Scope:

In this report, the Global Softgel Capsules Market has been segmented into the following categories:

By Type:

  • Gelatin-Based/Animal-Based
  • Non-Animal-Based

By Application:

  • Antacid and Anti-Flatulent Preparation
  • Anti-Anemic Preparations
  • Anti-Inflammatory Drugs
  • Antibiotic and Antibacterial Drugs
  • Cough and Cold Preparations
  • Health Supplement
  • Vitamin and Dietary Supplement
  • Pregnancy
  • Others

By End Use:

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Contract Manufacturing Organization

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Softgel Capsules Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Softgel Capsules Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Gelatin-Based/Animal-Based, Non-Animal-Based)
5.2.2. By Application (Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy, Others)
5.2.3. By End Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organization)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Softgel Capsules Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End Use
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Softgel Capsules Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By End Use
6.3.2. Canada Softgel Capsules Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By End Use
6.3.3. Mexico Softgel Capsules Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By End Use
7. Europe Softgel Capsules Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By End Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Softgel Capsules Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By End Use
7.3.2. France Softgel Capsules Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By End Use
7.3.3. United Kingdom Softgel Capsules Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By End Use
7.3.4. Italy Softgel Capsules Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By End Use
7.3.5. Spain Softgel Capsules Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By End Use
8. Asia Pacific Softgel Capsules Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End Use
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Softgel Capsules Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By End Use
8.3.2. India Softgel Capsules Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By End Use
8.3.3. Japan Softgel Capsules Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By End Use
8.3.4. South Korea Softgel Capsules Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By End Use
8.3.5. Australia Softgel Capsules Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
8.3.5.2.3. By End Use
9. Middle East & Africa Softgel Capsules Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End Use
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Softgel Capsules Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By End Use
9.3.2. UAE Softgel Capsules Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By End Use
9.3.3. South Africa Softgel Capsules Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By End Use
10. South America Softgel Capsules Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By End Use
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Softgel Capsules Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By End Use
10.3.2. Colombia Softgel Capsules Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By End Use
10.3.3. Argentina Softgel Capsules Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Softgel Capsules Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Fuji Capsule Co Ltd
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Sirio Pharma Co Ltd
15.3. Captek Softgel International Inc
15.4. Thermo Fisher Scientific Inc
15.5. EyePoint Pharmaceuticals Inc
15.6. Catalent Inc
15.7. EuroCaps Ltd
15.8. Aenova Group GmbH
15.9. Lonza Group AG
15.10. Soft Gel Technologies Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Fuji Capsule Co Ltd
  • Sirio Pharma Co Ltd
  • Captek Softgel International Inc
  • Thermo Fisher Scientific Inc
  • EyePoint Pharmaceuticals Inc
  • Catalent Inc
  • EuroCaps Ltd
  • Aenova Group GmbH
  • Lonza Group AG
  • Soft Gel Technologies Inc.

Table Information